News | Left Atrial Appendage (LAA) Occluders | July 26, 2023

Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device. 

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device. Air embolism can lead to injuries such as sudden (acute) reduction in blood flow to the heart (indicated by ST elevation), fast or slow heartbeat (tachycardia or bradycardia), low blood pressure (hypotension), and lack of enough oxygen in the blood (desaturation). Air embolism can also potentially lead to serious health consequences including stroke and death. 

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death. 

Recalled Product  

  • Product Name: Amplatzer Steerable Delivery Sheath  
  • Product Model: ASDS-14F-075 
  • Distribution Dates: October 4, 2022 to February 22, 2023 
  • Devices Recalled in the U.S.: 672 
  • Date Initiated by Firm: June 12, 2023 

Device Use 

The Abbott Amplatzer Steerable Delivery Sheath is a cardiac catheter inserted through the skin that provides a pathway for catheter-based devices to be introduced into the chambers of the heart. It is specifically used to deliver the Amplatzer Amulet Left Atrial Appendage Occluder. 

Reason for Recall  

Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles (air emboli) to be introduced into patients who have procedures with this device.  

Air embolism can lead to injuries such as sudden (acute) reduction in blood flow to the heart (indicated by ST elevation), fast or slow heartbeat (tachycardia or bradycardia), low blood pressure (hypotension), and lack of enough oxygen in the blood (desaturation). Air embolism can also potentially lead to serious health consequences including stroke and death. 

Abbott reports 26 incidents, 16 injuries, and no deaths related to this issue.  

Who May be Affected  

  • People having cardiac catheterization procedures with the Abbott Steerable Delivery Sheath.  
  • Healthcare providers who planned to use the Abbott Steerable Delivery Sheath for cardiac catheterization.   

What to Do  

On June 12, 2023, Abbott issued a Medical Device Recall notice to customers. The communication provided the following recommended actions: 

  • Return any remaining unused Amplatzer Steerable Delivery Sheaths to Abbott. Abbott representatives can assist with return of these devices. 
  • Use the fixed curve TorqVue 45°x45° delivery system for future Amplatzer Amulet Left Atrial Appendage Occluder implants. 
  • Complete and return the acknowledgment form attached to the notice to Abbott. 

Contact Information  

Customers with questions about this recall should contact their local Abbott representative or Abbott Support at 1-800-544-1664 (Option 2).  

Additional Resources:  

Medical Device Recall Database Entry 

How do I report a problem? 

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using the online form or call 1-800-332-1088 for more information on how to mail or fax the form. 


Related Content

News | FDA

April 25, 2024 — Provisio Medical announced FDA 510(k) clearance of the Provisio SLT IVUS System. Sonic Lumen Tomography ...

Home April 25, 2024
Home
News | FDA

April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food ...

Home April 24, 2024
Home
News | FDA

April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE Technologies ...

Home April 22, 2024
Home
News | FDA

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

Home April 18, 2024
Home
News | FDA

April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...

Home April 15, 2024
Home
News | FDA

April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular ...

Home April 12, 2024
Home
News | FDA

April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...

Home April 02, 2024
Home
News | FDA

April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...

Home April 02, 2024
Home
News | FDA

April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...

Home April 01, 2024
Home
News | FDA

March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...

Home March 28, 2024
Home
Subscribe Now